Giuseppe Giaccone, MD, PhD, highlights the difficulties with funding for research focused on rare cancers.
Giuseppe Giaccone, MD, PhD
Advertisement
Articles by Giuseppe Giaccone, MD, PhD
Giuseppe Giaccone, MD, PhD, discusses recent data with investigational therapies for patients with thymic cancer.
Giuseppe Giaconne, MD, PhD, discusses why thymic cancers can be difficult to classify histologically, so the actual incidence is unclear.
Giuseppe Giaconne, MD, PhD, and Yongfeng He, PhD, discuss how cancers of the thymus, a small organ located in the mediastinum above the heart, are uncommon and understudied.

Giuseppe Giaccone, MD, PhD, discusses current treatment options in non–small cell lung cancer.
Advertisement
Latest Updated Articles
Dr. Giaccone on Treatment Options in NSCLCOctober 1st 2020
- Dr. Giaccone on Investigational Agents in Thymic Cancers
October 21st 2022
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Gedatolisib Plus Fulvestrant ± Palbociclib for Hormone Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer
2
Frontline Sac-TMT Plus Pembrolizumab Meets PFS End Point in PD-L1–Negative, Nonsquamous NSCLC
3
Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer
4
Dr Cerchione on the FDA Approval of Subcutaneous Isatuximab in Myeloma
5
